Dr. Robert Montgomery, a pioneering transplant surgeon known for advancing organ transplantation techniques, underwent a heart transplant in September 2019 after facing years of severe heart failure. The procedure marked a significant personal and professional milestone for Montgomery, who had long been aware of his declining heart function due to a genetic form of dilated cardiomyopathy, the same condition that had affected his father and brother.

Montgomery’s journey began decades earlier. As a teenager, he was motivated to pursue medicine after witnessing his father’s battle with heart disease and witnessing the limitations of treatments available in the 1970s. Later, during his surgical residency at Johns Hopkins Medicine, he was confronted with his own diagnosis of the inherited condition, which threatened his ability to complete his training. To manage dangerous arrhythmias, Montgomery received an implantable cardioverter-defibrillator, a device designed to shock the heart back into normal rhythm during cardiac arrest episodes. Despite these interventions, he experienced multiple near-death events, including cardiac arrests during challenging moments such as hiking in Patagonia and attending public events.

Professionally, Montgomery established himself as an innovator in transplant surgery. At Johns Hopkins, he developed minimally invasive techniques to facilitate kidney donation from living donors and pioneered kidney exchange programs that significantly expanded access to transplants. His work also contributed to groundbreaking initiatives to increase organ availability by transplanting kidneys from donors with HIV into HIV-positive recipients, requiring federal legal changes to permit the practice. In 2016, Montgomery was recruited to lead the transplant program at NYU Langone Health in New York, where he continued to push boundaries in the field.

Montgomery’s declining health meant that despite his expertise, he faced the difficult reality of waiting for a scarce donor heart like many patients he had treated. Restrictions meant that patients often had to be critically ill to be listed for a heart transplant, and the supply was insufficient to meet demand. After several life-threatening cardiac events, including four arrests at a conference in Italy and a near-fatal episode during a Broadway show, Montgomery was finally listed for transplant and soon received a donor heart from a hepatitis C-positive individual. The transplant, involving a six-hour surgery, was part of a clinical trial, reflecting the increasing use of organs from donors infected with hepatitis C, as effective antiviral treatments can now manage the virus.

Since the operation, Montgomery has experienced a significant improvement in his health, resuming his surgical practice promptly and engaging actively in patient care. He has also continued his work toward expanding the pool of viable organs. In 2021, he led the first transplantation of a kidney from a genetically modified pig into a human, a brain-dead patient whose family consented to the procedure. The kidney functioned normally for the duration of the study, marking a breakthrough in xenotransplantation aimed at addressing organ shortages. Subsequent transplants of pig organs into terminally ill patients demonstrated the potential for overcoming immune rejection, a critical hurdle in transplant medicine.

Montgomery is currently leading clinical trials approved by the U.S. Food and Drug Administration to assess genetically modified pig organs in very ill patients lacking alternative treatment options. His personal experience as a transplant recipient has added new perspective to his clinical work, fostering deeper empathy with patients facing the uncertainty and challenges of organ failure and transplantation.

Despite the precarious nature of transplanted organs, which often require future interventions, Montgomery expresses optimism and a renewed sense of purpose. He maintains a rigorous schedule, dedicating himself to patient care, research, and advancing innovation in transplantation. His story underscores both the transformative power of transplant surgery and the persistent challenges posed by organ scarcity that continue to drive medical research and clinical innovation.